Linoleate sodium is an orally active regulator of IL8 mediated by JNK and NF-kappaB pathways. It can alter the composition of fatty acids and the production of metabolites within cells. Additionally, Linoleate sodium exhibits anti-inflammatory, immunomodulatory properties and influences tumor cell growth.
Molekulargewicht:
302.4273
CAS Nummer:
[822-17-3]
Formel:
C18H31NaO2
Target-Kategorie:
Interleukin|||NF-kappaB|||JNK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten